Global /South Korea /Healthcare /Drug Manufacturers - General /140410

Mezzion Pharma Co.,Ltd.

140410

• KRX: 140410 • Delayed

87,700KRW -8.7%

56.22 USD

As of 7 June 2026, Mezzion Pharma Co.,Ltd. has a market cap of $1.9B USD, ranking #7288 globally and #184 in South Korea. It ranks #593 in the Healthcare sector, and #234 in the Drug Manufacturers - General industry.

Global Rank

7288

Country Rank

184

Sector Rank

593

Industry Rank

234

Key Stats

Market Cap

$1.9BUSD

2.92T KRW

Enterprise Value

$1.86BUSD

2.9T KRW

Revenue (TTM)

$5.16MUSD

7.91B KRW

EBITDA (TTM)

-$10.16MUSD

-15.85B KRW

Net Income (TTM)

-$22.79MUSD

-34.93B KRW

EBITDA Margin

-200%

PS Ratio

368.9

PB Ratio

169.7

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Dong-Hyun Park open_in_new

Employees

Founded

2002

Website

mezzion.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-8.7%	6.3%	-2%	-43%	58%	6.5%	150%	340%	88%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	140410 (주)메지온 ISIN: KR7140410002 Shares Out.: Shares Outstanding: 30.392M¹ Shares Float: 22.14M² TV: TradingView: KRX: 140410 SA: Stock Analysis: KRX: 140410 YF: Yahoo Finance: 140410.KS GF: Google Finance: KRX: 140410 BA: Barron's: 140410 MS: Morningstar: XKRX: 140410	87,700 KRW	TV: TradingView: KRX: 140410 SA: Stock Analysis: KRX: 140410 YF: Yahoo Finance: 140410.KS GF: Google Finance: KRX: 140410 BA: Barron's: 140410 MS: Morningstar: XKRX: 140410

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Mezzion Pharma Co.,Ltd.

Mezzion Pharma Co.,Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company developing JURVIGO, which is in Phase 3 clinical trial for treatment option to improve the physiology and exercise capacity of Fontan patients 12 years and older. The company was formerly known as Dong-A Pharmtech Co., Ltd. and changed its name to Mezzion Pharma Co.,Ltd. in April 2013. Mezzion Pharma Co.,Ltd. was founded in 2002 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.07B 13.91T KRW 377%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.72B 10.3T KRW 253%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.2B 7.97T KRW 173%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.92B 7.55T KRW 159%	-	South Korea
Yuhan Corp. KRX: 000100	$4.51B 6.92T KRW 137%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.41B 6.76T KRW 132%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 40K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 29K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 19K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 17K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 15K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 14K%	20.5	Switzerland

chevron_leftBack